New hope against deadly superbug fungus?
NCT ID NCT04148287
First seen Nov 01, 2025 · Last updated May 08, 2026 · Updated 23 times
Summary
This study tested a new drug called APX001 in 9 adults with a serious fungal infection (Candida auris) in the blood or organs that didn't respond to standard treatments. The goal was to see if the drug could clear the infection and help patients survive. The study was small and early-stage, so results are limited but provide initial safety and effectiveness data.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANDIDEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Milpark Academic Trauma Centre
Johannesburg, Gauteng, 2193, South Africa
-
Netcare Union Hospital Trauma Surgeons
Alberton, Gauteng, 1449, South Africa
Conditions
Explore the condition pages connected to this study.